OBI-904

N/A

Report date: 2024/04/10 12:03:45

Base Information

Drug NameOBI-904

Drug Alias NameOBI-904

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionAnti-NECTIN4DNA topoisomerase I inhibitors

TargetsNectin-4DNA topoisomerase I

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesObi Pharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesObi Pharma Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A